Back to Search Start Over

Studies from Alfaisal University Further Understanding of Artificial Intelligence (The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective).

Source :
Medical Letter on the CDC & FDA; 12/17/2023, p384-384, 1p
Publication Year :
2023

Abstract

A report from Alfaisal University in Saudi Arabia discusses the application of artificial intelligence (AI) in diabetic retinopathy (DR) screening. DR is a leading cause of preventable blindness in Saudi Arabia, and the country does not currently have a national screening program for the disease. The study aimed to evaluate the perception and acceptance of AI in DR screening among eye care professionals in Saudi Arabia. The results showed that most participants had good knowledge about AI and had a positive attitude towards AI-based DR screening. However, concerns about the labor market and data confidentiality were also evident, suggesting a need for further education and awareness on the topic. [Extracted from the article]

Details

Language :
English
ISSN :
15324648
Database :
Complementary Index
Journal :
Medical Letter on the CDC & FDA
Publication Type :
Periodical
Accession number :
174071339